Novel Studies Underway at DHR Health to Find a Treatment for the Relatively High Incidence of Liver Diseases in the Predominantly Hispanic Community in South Texas

Translate to Spanish or other 102 languages!

Image for illustration purposes only

Mega Doctor News

- Advertisement -

Edinburg, TX – The prevalence of chronic liver diseases particularly among Hispanics in the United States has been steadily increasing in the last 2-3 decades. It is estimated that over 30% of people of Hispanic ethnicity in our community are suffering from chronic liver diseases namely Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH). While NAFLD/NASH are highly associated with many metabolic conditions (such as type 2 diabetes,  obesity, hypertension, hyperlipidemia, etc.), there is a strong genetic predisposition particularly in Hispanic population. This trend has been made more alarming by the pandemic spread of obesity in children as weight-gain during school-years carries a higher risk of NAFLD/NASH than weight-gain in late adulthood. Therefore, both nature and nurture play a significant role in the steady increase in the incidence of NAFLD/NASH in people of Hispanic ethnicity. 

NAFLD is a silent form of chronic liver disease that is suspected after elevated liver enzymes are detected in patient’s blood and is subsequently confirmed by MRI and liver biopsy. NASH is the detrimental form of chronic liver disease that if untreated, progresses to liver cirrhosis and liver cancer. Unlike in the past, NAFLD/NASH are now the leading causes of liver transplantation in the United States. Unfortunately, currently there is no FDA approved drug in the market to treat NAFLD/NASH necessitating the need to conduct clinical studies particularly in ethnic groups most affected by this disease.

“We are involved in a number of cutting-edge and innovative clinical trials aimed at the prevention and/or delay in progression of chronic liver diseases such as NAFLD/NASH” said dr. sohail rao, president and chief executive officer, DHR Health Institute for Research & Development. “Working with our community that is at a much higher predisposition to develop these chronic liver diseases, we are determined to find a treatment for this growing endemic.”

- Advertisement -

To get more information and/or to refer your patient, please contact (956)362-8047 or (956)362-2390 or visit dhrresearch.org

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Eating and sleeping later associated with increased health risks

Staying up late and eating later in the evening could increase the risk of metabolic syndrome, a term that refers to conditions that increase the risk of type 2 diabetes, cardiovascular disease, and high cholesterol.

Health Officials Release Joint Statement Regarding Loss of U.S. Measles Elimination Status

CDC and its partners are committed to stopping measles outbreaks, protecting Americans, and regaining measles elimination status.

Why Kids Need Less Screen Time Before Bed

Phone notifications can feel nonstop – even for kids. Brian Chen, MD, a sleep specialist with Cleveland Clinic Children's, said it’s important to make sure those are muted and that screens are limited before bedtime.

Keep Thanksgiving Stress-Free with STHS Food Safety Tips

The holiday season is a time for gathering with loved ones, celebrating family traditions and enjoying home-cooked meals. 
- Advertisement -